Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

European Union and Business Finland provide Biohit Oyj with a total of EUR 900,000 in financing for product development

Biohit Oyj Press release 8th March 2021 at 10.00 am local time (EET)   Biohit Oyj has received a total of EUR 900,000 in funding from the EU through the Eurostars program and also from Business Finland for the development and launch of rapid tests over the next three years. The Eurostars program is a joint program of 36 countries managed by the EUREKA Secretariat in Brussels as part of international EUREKA cooperation. The financing of the Finnish parties comes from Business Finland. The funding is a grant primarily to SMEs. Biohit's CEO Semi Korpela states: “Funding granted by

Olvi plc will become even stronger in Latvia through acquisition

Olvi plc                      Stock Exchange Release 8 MAR 2021 at 10:00 am Olvi plc will become even stronger in Latvia through acquisitionOlvi’s Latvian subsidiary AS Cesu Alus is a leading player in the Latvian beverage market. Cesu Alus is acquiring the entire stock of Piebalgas Alus, a widely known and appreciated microbrewery in the Vidzeme province of Latvia. The acquisition brings more strength to our product portfolio in premium craft beers and kvass in the retail and HoReCa markets. The Piebalga brewery was established in 1989. It is devoted to traditional manufacturing

Finnish researchers introduce a nasal COVID vaccine

Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland. The vaccine uses gene transfer technology developed at the University of Eastern Finland by Academy Professor Seppo Ylä-Herttuala’s research group, and the technology has already been successfully used in several clinical trials using gene therapy to treat cardiovascular diseases and cancer. The vaccine

Medivir to present at the H.C. Wainwright Global Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will present at the virtual meeting H.C. Wainwright Global Life Sciences Conference, March 9-10. The presentation will be available via Medivirs website; www.medivir.com. More information about the event is available at the organizer’s website: https://hcwevents.com/globalconference/   For additional information, please contactYilmaz Mahshid, CEOTelephone: +46 8 5468 3100E-mail: yilmaz.mahshid@medivir.com Magnus Christensen, CFOTelephone: +46 8 5468 3100E-mail: magnus.

Kamux Corporation: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act

Kamux Corporation     Stock Exchange Release (Flagging Release) 8 March 2021 at 9:30 (EET) Kamux Corporation: Flagging notification in accordance with Chapter 9, Section 10 of the Securities Markets Act Kamux Corporation has on March 5, 2021 received an announcement under Chapter 9, Section 5 of the Securities Markets Act, according to which the total holdings of shares and voices of Juha Kalliokoski and Callardo Capital Oy in Kamux Corporation has fallen below the 15 percent threshold. According to the notification on March 5, 2021 Juha Kalliokoski and Callardo Capital Oy, a company

Calliditas strengthens its US Commercial and Medical Affairs Organization

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced the appointment of three industry veterans: Warren Brooks, PhD, as Vice President of US Medical Affairs, Teona Johnson as Head of US Marketing and David Ferraro as Head of US Sales.Calliditas Therapeutics has bolstered its US organization with three pharmaceutical veterans as it moves towards the potential commercialization of its lead product candidate, Nefecon. “This is an important step on our continued path to deliver on our promise to build a center of excellence in the US. This shows our long term commitment to

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210305224852_2 ____________________________________________ Transaction date: 2021-03-04 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the

Alfa Laval starts testing new fuels to support the transition towards more sustainable shipping

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – will soon start testing two new types of marine fuels; biofuels (made from waste) and methanol, in its Test & Training Centre in Denmark. To make these non-carbon fuels commercially viable can have a big impact on the marine industry in its strive towards zero carbon shipping.The International Maritime Organization (IMO) targets a 50 percent reduction of vessel-related greenhouse gas emissions by 2050. To achieve the long-term target of decarbonization, the industry must shift to new fuel types and

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210307233612_2 ____________________________________________ Transaction date: 2021-03-04 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the

NENT Group acquires top women’s football for Viaplay in 9 countries

· Women’s Super League rights extended for three years until 2024 in Sweden, Norway, Denmark, Finland, Iceland and acquired for new markets Estonia, Latvia, Lithuania and Poland · Women’s Serie A, Frauen Bundesliga, Danish League (Gjensidige Kvindeliga) and selected matches from Spain’s Liga Iberdrola also secured for the same markets · NENT Group continues to focus investments on women’s sports in all territories Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has secured a comprehensive package of women’s top football for its streaming

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210305225332_2 ____________________________________________ Transaction date: 2021-03-04 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210305230042_2 ____________________________________________ Transaction date: 2021-03-04 Venue not applicable Instrument type: SHARE ISIN: FI4000206750 Nature of the

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Kalliokoski Lilja Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kalliokoski Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210305231602_2 ____________________________________________

Kamux Oyj - Managers' Transactions

Kamux Corporation   Managers’ Transactions    8 March 2021 at 09:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Kalliokoski, Juha Position: Chief Executive Officer Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 743700KCVYIYNLPZYN56_20210305231044_2 _______________________

Gapwaves has received a new order of a new Development project from Uhnder

Gapwaves has received an order for a new project from American Uhnder. The delivery includes design / development and production of 300 metallized, injection molded antennas for a 77 GHz high resolution radar intended for robotic transports. The total order value is approximately SEK 1.6 million and delivery is expected to take place during the third quarter of 2021.In March 2020 Gapwaves started a collaboration with Uhnder, an Austin, Texas based company, that has developed a unique digital Radar-on-Chip (RoC), using a combination of advanced CMOS and Digital Code Modulation (DCM)

Northmill Bank launches an initiative to support women’s football in Sweden

– The initiative Power of We starts with 32 clubs from Division 1 to 5Stockholm, 8 March 2021: The neobank Northmill , which has the vision to improve financial life, launches a major initiative to support grassroots sports in Sweden, focusing on women’s football from Division 1 to 5. More than 30 clubs spread across the country are included in this initiative called Power of We - with the aim to form a grassroots movement encouraging physical education and health, as well as supporting clubs in a way that truly makes a difference. The ongoing

Motorcycle ambulances to help reduce maternal mortality in rural Africa

In autumn 2020, Semcon partnered in a development project with Eezer Initiativet, which develops and implements unique motorcycle ambulances to reduce maternal mortality in East and Central Africa. The goal is to make it easier for pregnant women and new mothers to get to hospitals. The project, which is now moving into the next phase, is part of Semcon’s CSR programme.In the African countryside, the nearest hospital can be a long way away, and getting there often means travelling through rough terrain. By using ambulance wagons towed behind motorcycles, more women can get access to care

Proud partner in the renovation of St Paul’s

Wallenstam is a proud donor and partner in the Stockholm City Mission’s major investment in the reconstruction of St Paul's Church at Mariatorget in Stockholm. St Paul’s has long meant a safe place for Stockholm City Mission participants, offering the possibility of support in the form of food, warmth, advice and a sense of togetherness. The vision is to create a meeting point with a large welcoming space, primarily for Stockholm City Mission participants, but also for everyone who wants to deepen their social engagement.In March, the realization of the vision will start, and the

Nightingale announces a fixed subscription price and publishes a prospectus for its contemplated IPO and listing of its series B shares on Nasdaq First North Growth Market Finland

Company Release 8 March 2021 at 9:05 Finnish time NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nightingale announces a fixed subscription price and publishes a prospectus for its contemplated IPO and listing of its shares on Nasdaq First North Growth Market Finland. Nightingale Health Plc (“Nightingale” or the “Company”) today announced the subscription price for its

Nightingale has applied for its series B shares to be listed on Nasdaq First North Growth Market Finland and commences the initial public offering

Company Release 8 March 2021 at 9:05 Finnish time NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nightingale Health Plc (“Nightingale” or the “Company”) today announced that it has today filed a listing application with Nasdaq Helsinki Ltd for listing of the Company’s series B shares on Nasdaq First North Growth Market Finland maintained by Nasdaq Helsinki Ltd (“First North

Finnair Plc - Managers' transactions - Pienimäki

Finnair Plc, Managers’ Transactions, 08 March 2021 at 09:04 am EET____________________________________________ Person subject to the notification requirementName: Pienimäki, TomiPosition: Other senior managerIssuer: Finnair PlcLEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATIONReference number: 213800SB6EOB8SSK9W63_20210305120812_156____________________________________________ Transaction date: 2021-03-04Venue: XHELInstrument type: SHAREISIN: FI0009003230Nature of the transaction: ACQUISITIONFurther details: Quarterly acquisition under the

Finnair Plc - Managers' transactions - Orvér

Finnair Plc, Managers’ Transactions, 08 March 2021 at 09:03 am EET____________________________________________ Person subject to the notification requirementName: Orvér, MatsPosition: Other senior managerIssuer: Finnair PlcLEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATIONReference number: 213800SB6EOB8SSK9W63_20210305120812_158____________________________________________ Transaction date: 2021-03-04Venue: XHELInstrument type: SHAREISIN: FI0009003230Nature of the transaction: ACQUISITIONFurther details: Quarterly acquisition under the employee

Finnair Plc - Managers' transactions - Manner

Finnair Plc, Managers’ Transactions, 08 March 2021 at 09:02 am EET____________________________________________ Person subject to the notification requirementName: Manner, TopiPosition: Chief Executive OfficerIssuer: Finnair PlcLEI: 213800SB6EOB8SSK9W63 Notification type: INITIAL NOTIFICATIONReference number: 213800SB6EOB8SSK9W63_20210305120812_159____________________________________________ Transaction date: 2021-03-04Venue: XHELInstrument type: SHAREISIN: FI0009003230Nature of the transaction: ACQUISITIONFurther details: Quarterly acquisition under the

There are no items matching the current filter
There are no more items matching the current filter
Back to top